These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1469 related items for PubMed ID: 9599650

  • 1. Molecular genetics of von Willebrand disease.
    Mazurier C, Ribba AS, Gaucher C, Meyer D.
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [Abstract] [Full Text] [Related]

  • 2. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 3. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E, Mazurier C, Meyer D.
    Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
    [Abstract] [Full Text] [Related]

  • 4. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Jan; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 5. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [Abstract] [Full Text] [Related]

  • 6. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.
    Acta Haematol; 2009 Oct; 121(2-3):145-53. PubMed ID: 19506361
    [Abstract] [Full Text] [Related]

  • 7. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 8. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Nov; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 9. Molecular basis of von Willebrand disease.
    Mazurier C, Meyer D.
    Baillieres Clin Haematol; 1996 Jun; 9(2):229-41. PubMed ID: 8800502
    [Abstract] [Full Text] [Related]

  • 10. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
    Meyer D, Fressinaud E, Hilbert L, Ribba AS, Lavergne JM, Mazurier C.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):349-64. PubMed ID: 11686104
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C, de Romeuf C, Rauïs-Morret M, Corazza F, Fondu P, Mazurier C.
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [Abstract] [Full Text] [Related]

  • 12. Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.
    Baronciani L, Federici AB, Cozzi G, Canciani MT, Mannucci PM.
    J Thromb Haemost; 2007 Feb; 5(2):282-8. PubMed ID: 17155947
    [Abstract] [Full Text] [Related]

  • 13. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HH.
    Acta Haematol; 2009 Feb; 121(2-3):85-97. PubMed ID: 19506353
    [Abstract] [Full Text] [Related]

  • 14. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C, Hilbert L, Mazurier C.
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [Abstract] [Full Text] [Related]

  • 15. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U, Drewke E, Mainusch K, Schneppenheim R.
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [Abstract] [Full Text] [Related]

  • 16. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S, Bowen D, Cumming A, Enayat S, Goodeve A, Hill M, UK Haemophilia Centre Doctors' Organisation (UKHCDO).
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [Abstract] [Full Text] [Related]

  • 17. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 18. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC, Lin JS, Lin DS, Hsu SC, Lin B.
    Thromb Res; 2003 Apr; 112(5-6):291-5. PubMed ID: 15041272
    [Abstract] [Full Text] [Related]

  • 19. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
    Hilbert L, Jenkins PV, Gaucher C, Meriane E, Collins PW, Pasi KJ, Mazurier C.
    Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
    [Abstract] [Full Text] [Related]

  • 20. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.